Company / Operating Cash Flow per Share
Roivant Sciences Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.10
FY2025
5-year range
-$1.10 / -$0.85
FY2021-FY2025
Trend
-5.7%
vs FY2024
Sector context
#119 of 212
Health Care
What the data says
At $-1.10, Roivant Sciences's operating cash flow per share ranks #119 of 212 in the Health Care sector. Operating Cash Flow per Share has declined for 3 consecutive years, from $-0.85 in FY2022 to $-1.10 in FY2025.
Based on SEC 10-K filings.
-1.10 in FY2025.
Declined from $-1.01 to $-1.10 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 212 in Health CareTop 56% of 212This company -$1.10 Sector average $5.28
▼
-120.8% below sector average
Key checks
Key Insights
- Roivant Sciences's operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 5.7% year-over-year.
- Ranks #119 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | -5.7% |
| FY2024 | -$1.04 | -3.4% |
| FY2023 | -$1.01 | -18.8% |
| FY2022 | -$0.85 | +16.3% |
| FY2021 | -$1.01 | -15.5% |
| FY2020 | -$0.88 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026